Clinical Analysis: Type 1 Diabetic Patient with Leg Muscle Pain

Symptom Deconstruction

Provisional Diagnoses

1. Diabetic Muscle Infarction (DMI) — Most Likely Primary Diagnosis

• Occurs in patients with long-standing poorly controlled diabetes with established microangiopathy (as in this patient — microalbuminuria from day 1)
• Usually affects thigh muscles, but can involve calf
• Classically presents with pain at rest, a palpable tender mass, and decreased function — not worsening with activity in the typical claudication pattern
• NCS is normal — as in this patient — because this is a muscle problem, not a nerve problem
• Mechanism: occlusion of small intramuscular arteries due to diabetic microangiopathy → ischemic muscle infarction
• Microalbuminuria (marker of generalised microangiopathy) being present since diagnosis strongly supports this

"A painful condition of infarction of the muscle on one side is seen in diabetic patients." — Adams and Victor's Principles of Neurology, 12th Ed.

"Diabetic muscle infarction (usually of the thigh)... [are] musculoskeletal conditions that occur with increased frequency in diabetic patients." — Goldman-Cecil Medicine

2. Diabetic Amyotrophy (Diabetic Lumbosacral Radiculoplexus Neuropathy) — Important Differential

• Also called Bruns-Garland syndrome; a lumbar polyradiculopathy (L2–L4)
• Presents with severe pain, dysesthesias, and rapid atrophy of proximal thigh muscles
• Can be bilateral
• NCS may be normal in early stages or may show only subtle changes depending on what is tested
• However, EMG (not NCS) typically shows denervation changes in affected muscles
• The relief with contraction is less characteristic here

"Diabetic amyotrophy is a lumbar polyradiculopathy (L2 to L4) that arises with severe pain, dysesthesias, and rapid atrophy of the proximal muscles of one or both thighs." — Goldman-Cecil Medicine

3. Statin-Induced Myopathy — Must Rule Out

• If the patient was started on a statin at any point (common in diabetics for cardiovascular risk reduction)
• Presents with proximal muscle pain, weakness, fatigue, exercise intolerance
• CK elevation is the key marker
• NCS normal

4. Inflammatory Myopathy (Polymyositis) — Less Likely but Consider

• Proximal muscle weakness, pain, elevated CK, elevated ESR/CRP
• Can coexist with diabetes
• NCS normal; EMG would show myopathic pattern

5. Diabetic Cheiroarthropathy / Musculoskeletal Complications of DM — Contributing

• Long-standing Type 1 DM causes glycosylation of tendons, collagen cross-linking → restricted joint mobility, stiffness
• This explains the restriction of movement component

Next Steps

Immediate Investigations

Clinical Examination Focus

• Palpate the muscle — tender indurated mass in DMI
• Joint range of motion — for cheiroarthropathy, frozen shoulder, trigger finger
• Neurological exam — reflexes, power testing proximal vs distal
• Vascular exam — peripheral pulses, ABI (ankle-brachial index) to rule out PAD
• Fundoscopy — diabetic retinopathy as marker of microangiopathy severity

Management (Once Diagnosis Confirmed)

• Strict glycaemic control — most important intervention; optimise insulin regimen
• Rest + analgesics (NSAIDs/COX-2) — for acute pain
• Avoid biopsy if MRI is diagnostic — risk of haematoma, infection, delayed healing
• Physiotherapy — gentle, gradual mobilisation after acute phase
• Continue Telmisartan — nephroprotection and vascular protection (ARB also has some benefit in microangiopathy)
• Antiplatelet therapy (e.g., aspirin) — if not already on it
• Statin — for cardiovascular risk reduction (if CK normal and no statin myopathy)

• Glycaemic optimisation
• Pain management (gabapentin, pregabalin, TCAs, SNRIs)
• Physiotherapy
• May improve spontaneously over months

Summary Flowchart

Type 1 DM (10 yrs) + Microalbuminuria + Normal NCS
+ Rest pain relieved by contraction + Reduced exercise tolerance
       ↓
Provisional Dx: Diabetic Muscle Infarction
       ↓
MRI Muscle → Focal edema/infarction → Confirm DMI
       ↓
EMG → Rules out amyotrophy/neuropathy
CK, ESR → Rules out myositis/statin myopathy
HbA1c → Guides glycaemic optimisation

Revised Analysis with Updated Clinical Picture

Updated Symptom Profile

To Your Questions Directly

Question 1: Is Serum CK Enough, or Are MRI, LDH, and Aldolase Still Needed?

• If CK is normal → active inflammatory myopathy and significant ongoing muscle necrosis (from DMI or myositis) are effectively ruled out. No further muscle enzyme workup (LDH, Aldolase) is necessary in that scenario.
• If CK is mildly elevated → could still reflect residual statin effect (statin was stopped 8 years ago — very unlikely to be causally relevant now, but rhabdo-myopathy resolves within weeks of stopping), or low-grade myositis → then LDH and Aldolase add confirmatory value.
• If CK is significantly elevated → then MRI muscle becomes indicated to map extent and nature of involvement.

Summary: CK first → if abnormal, add LDH/Aldolase and consider MRI. If CK normal, move to RLS workup.

Question 2: Why Was Restless Legs Syndrome Not Considered? — A Valid Criticism

"The four core symptoms required for diagnosis are an urge to move the legs usually caused or accompanied by an unpleasant sensation in the legs; symptoms that begin or worsen with rest; partial or complete relief by movement; and worsening during the evening or night." — Harrison's Principles of Internal Medicine, 22nd Ed.

"Restless legs syndrome is characterized by four essential features: discomfort or urge to move the legs, worsening with rest, improvement with movement, and worsening in the evening." — Goldman-Cecil Medicine

1. Diabetes is a recognised secondary cause of RLS — peripheral neuropathy (even subclinical, before NCS becomes abnormal) and small-fibre neuropathy are linked to RLS. NCS being normal does not exclude small-fibre or autonomic neuropathy.
2. Microalbuminuria → subclinical CKD risk — CKD/uraemia is one of the most common secondary causes of RLS (mentioned in Harrison's in the context of CKD neuromuscular complications). Even stage 2–3 CKD can cause RLS.
3. Iron deficiency — another major secondary cause of RLS; should be checked.
4. The "gym performance reduced + fatigue" can be explained by sleep disruption from nocturnal RLS → chronic sleep deprivation → reduced exercise capacity.

Revised Provisional Diagnoses (Ranked)

1. Restless Legs Syndrome (RLS) — primary diagnosis; all 3 confirmed criteria met (4th to be asked about)
2. Statin-Induced Myopathy (residual/late effect) — less likely 8 years after stopping, but CK will confirm/exclude
3. Diabetic Small-Fibre Neuropathy — NCS normal but small fibres not tested; can coexist with and cause RLS
4. Subclinical CKD-related RLS — check eGFR/creatinine; microalbuminuria patient may have reduced GFR
5. Diabetic Muscle Infarction — now deprioritised (no tenderness, no focal mass)

Revised Next Steps (Streamlined)

Must-Ask History

• Does the pain/urge worsen in the evening or at night specifically? (4th RLS criterion)
• Is sleep disturbed? Daytime fatigue?
• Any creeping/crawling/burning sensations, or is it purely pain?
• Caffeine, alcohol, antihistamine, antidepressant use? (RLS aggravators)

Investigations

Management if RLS Confirmed

1. Treat secondary causes first:
   • Correct iron deficiency (ferritin target >75 µg/L for RLS)
   • Optimise glycaemic control (HbA1c)
   • Review medications that worsen RLS (antihistamines, SSRIs, dopamine antagonists)
   • Continue Telmisartan (nephroprotection)
2. Pharmacological (if no correctable secondary cause):
   • Gabapentin or Pregabalin — preferred in diabetic patients (also covers any neuropathic component)
   • Dopamine agonists (pramipexole, ropinirole) — effective but now avoided as first-line due to risk of augmentation (worsening of symptoms over time)
   • Rotigotine patch — alternative
   • Low-dose opioids — for refractory cases

"Dopamine agonists are now avoided because they augment the intensity and duration of daily symptoms... gabapentin or pregabalin can be tried." — Goldman-Cecil Medicine